Pulmonx Corp (LUNG) - Market Cap to Earnings

Corporate emblem and logo of Pulmonx (LUNG)

The price trend visualization for Pulmonx Corporation (LUNG) on the GURU.Markets platform demonstrates the -3.00 indicator. Pulmonx Corporation (LUNG) focuses on the development of lung valves, utilizing external contractors for the final assembly of the products. Growth prospects depend on the recognition of the emphysema treatment method and the expansion of insurance reimbursements. Supply stability is guaranteed by the availability of backup components and the diversification of electronics partners.

Pulmonx Corp (LUNG): Price to Earnings Ratio from 07/04/2022 to 11/16/2026

Comprehensive metric breakdowns and analytics for pulmonx.com (LUNG)

General company analysis:Pulmonx Corp - LUNG
Manufactured product of Pulmonx Corporation

The P/E ratio reflects the market value of a single unit of net profit, allowing an investor to assess the extent to which an asset is overvalued or undervalued relative to its actual earnings. When analyzing the price-to-earnings ratio of Pulmonx Corporation (LUNG), it is critical to consider the metric's sensitivity to quarterly reports, which in the case of Pulmonx Corporation confirms the effectiveness of management's strategy to protect margins during the expansion of the Zephyr system.

Analysis of competing companies

Dexcom - Market Cap to Net Income|Price to Earnings Ratio PEN (Penumbra Inc)|NOVT - Market Cap to Earnings|Haemonetics Corp. - Price to Earnings Ratio|P/E Multiple Inspire Medical Systems, Inc. INSP|PRCT: Price to Earnings Ratio|CONMED - Market Price to Net Income Ratio|PLSE: P/E Multiple|INMD - Business Payback Period|Price to Earnings Ratio PMI|Price to Earnings Ratio Surmodics (SRDX)|Price to Earnings Ratio SENS (Senseonics Holdings, Inc.)|NPCE (NeuroPace Inc) - Company Value to Net Income|Price to Earnings Ratio Tactile Systems Technology TCMD|SNWV - Price to Earnings Ratio|outsetmedical.com - P/E Multiple|Market Cap to Earnings smartvest.com|LNSR: P/E Multiple|Price to Earnings Multiple RCEL|PROF (Profound Medical) - P/E Multiple|Baird Medical Investment (BDMD) - Business Payback Period|P/E Multiple EDAP|Price to Earnings Ratio Apyx Medical Corporation APYX|P/E Multiple ICCM (IceCure Medical Ltd.)|P/E Multiple TELA Bio, Inc. TELA|CTSO - Price to Earnings Ratio|SRTS: Price to Earnings Ratio|ZYXI (Zynex, Inc.) - Price to Earnings Ratio|electroCore Inc - Company Value to Net Income|RBOT (Vicarious Surgical Inc) - P/E Multiple|Market Cap to Earnings inspira-technologies.com IINN|Price to Earnings Ratio ICU (SeaStar Medical Holding Corporation)|IRIDEX Corp. (IRIX) - Market Cap to Net Income Ratio|Intelligent Bio Solutions Inc - Price to Earnings Ratio|P/E Multiple AINostix XAIR|Profusa Inc. - P/E Multiple|Business Payback Period STRATA Skin Sciences, Inc. SSKN|GlucoTrack (GCTK) - Price to Earnings Ratio|Market Cap to Net Income NAOV (NanoVibronix Inc.)|Price to Earnings Ratio venusconcept.com|Price to Earnings Ratio Nuwellis, Inc. (NUWE)|P/E Multiple AEMD|ASXC - Market Cap to Earnings|Price to Earnings Ratio Avinger, Inc. AVGR|BSGM: Price to Earnings Multiple|CUTR: Price to Earnings Ratio|KNW - P/E Multiple|NARI: P/E Multiple|Price to Earnings Multiple NVRO|RSLS (ReShape Lifesciences, Inc.) - P/E Multiple|Silk Road Medical Inc (SILK) - Business Payback Period